Gilead Sciences, Inc. (GILD) Stock Forecast
GILD analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.32 / 5 from 28 analysts
- Price target
- $159.85 average of analyst targets
- Upside to target
- +2.3% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $2.16
- 52-week range
- $117.88 – $157.37
GILD analyst ratings
28 analystsNumber of analysts at each rating.
GILD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GILD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.20 | $1.99 | $2.68 | $2.47 | −10.9% | 22 |
| Current fiscal year (2026) | −$0.40 | −$0.62 | −$0.02 | $8.15 | −104.9% | 27 |
| Next fiscal year (2027) | $9.94 | $9.19 | $11.44 | −$0.40 | +2,586.6% | 25 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GILD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $7.79B | $7.66B | $7.95B | +0.3% | 20 |
| Current fiscal year (2026) | $30.73B | $30.31B | $31.18B | +4.4% | 25 |
| Next fiscal year (2027) | $32.84B | $31.92B | $33.74B | +6.9% | 23 |
GILD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GILD revenue: reported and forecast
GILD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.23 | $2.15 | $2.15 | $2.18 | $2.20 | −1.2% | 5 up · 2 down |
| Current fiscal year (2026) | −$0.77 | −$0.43 | −$0.43 | −$0.41 | −$0.40 | −48.2% | 6 up · 1 down |
| Next fiscal year (2027) | $9.71 | $9.89 | $9.89 | $9.92 | $9.94 | +2.4% | 5 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GILD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GILD beat in 11 of 12.
What analysts expect from GILD
28 analysts cover Gilead; their consensus rating is buy (4.32 on a 1–5 scale, where 5 is a strong buy). The average price target is $159.85, 2.3% above the latest close of $156.19. Analysts expect earnings of −$0.40 per share for 2026, −104.9% from a year earlier. For 2027 the average estimate is $9.94 per share on revenue of $32.8 billion. Gilead beat the EPS estimate in 11 of the last 12 quarters.
Related: GILD income statement, GILD key metrics, GILD chart. See the GILD stock overview for the latest quote and news.
GILD forecast FAQ
What is Gilead's price target?
The average analyst price target for Gilead is $159.85, 2.3% above the latest close of $156.19.
Is Gilead a buy, hold or sell?
Of 28 analysts covering Gilead, 16 rate it a strong buy, 6 a buy, 5 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Gilead's EPS forecast?
Analysts forecast −$0.40 per share for 2026 (range −$0.62 to −$0.02); for 2027 the estimate is $9.94.
What is Gilead's revenue forecast?
The average revenue estimate for 2026 is $30.7 billion, growth of 4.4%; for 2027 it is $32.8 billion.
When does Gilead report earnings?
Gilead is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes; the EPS estimate is $2.16.
Does Gilead usually beat earnings estimates?
Gilead reported EPS at or above the analyst estimate in 11 of the last 12 quarters.